Shakeri, A. and Adanty, C. (2020) “Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review”, Journal of Population Therapeutics and Clinical Pharmacology, 27(1), pp. e25-e31. doi:10.15586/jptcp.v27i1.655.